DexCom

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. 

CEO
Jacob S. Leach
CEOJacob S. Leach
Employees
11,100
Employees11,100
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1999
Founded1999
Employees
11,100
Employees11,100

DXCM Key Statistics

Market cap
33.17B
Market cap33.17B
Price-Earnings ratio
35.41
Price-Earnings ratio35.41
Dividend yield
Dividend yield
Average volume
2.91M
Average volume2.91M
High today
$89.00
High today$89.00
Low today
$87.65
Low today$87.65
Open price
$88.78
Open price$88.78
Volume
2.27M
Volume2.27M
52 Week high
$92.59
52 Week high$92.59
52 Week low
$54.11
52 Week low$54.11

Stock Snapshot

DexCom(DXCM) stock is priced at $87.90, giving the company a market capitalization of 33.17B. It carries a P/E multiple of 35.41.

On 2026-09-04, DexCom(DXCM) stock moved within a range of $87.65 to $89.00. With shares now at $87.90, the stock is trading +0.3% above its intraday low and -1.2% below the session's peak.

Trading activity shows a volume of 2.27M, compared to an average daily volume of 2.91M.

The stock's 52-week range extends from a low of $54.11 to a high of $92.59.

The stock's 52-week range extends from a low of $54.11 to a high of $92.59.

DXCM News

Barron's 2d
Revisiting Stock Picks Dexcom, Bristol Myers Squibb, Quanta Services

You are now leaving Barron's website By clicking on the “Proceed” button below, you will be redirected to a third-party website owned and operated by Hong Kong...

Revisiting Stock Picks Dexcom, Bristol Myers Squibb, Quanta Services
MarketWatch 3d
DexCom Inc. stock outperforms competitors despite losses on the day - MarketWatch

...

DexCom Inc. stock outperforms competitors despite losses on the day - MarketWatch
Simply Wall St 4d
G7 Momentum and Global Reach Might Change The Case For Investing In DexCom

In the past quarter, DexCom, Inc. reported that new G6 and G7 continuous glucose monitoring systems, together with broader international distribution, helped su...

G7 Momentum and Global Reach Might Change The Case For Investing In DexCom

Analyst ratings

84%

of 31 ratings
Buy
83.9%
Hold
16.1%
Sell
0%

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.